
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Nutr. , 01 April 2025
Sec. Nutrition and Food Science Technology
Volume 12 - 2025 | https://doi.org/10.3389/fnut.2025.1521516
This article is a correction to:
The future of cow’s milk allergy – milk ladders in IgE-mediated food allergy
A Corrigendum on
The future of cow's milk allergy – milk ladders in IgE-mediated food allergy
by Hicks, A., Fleischer, D., and Venter, C. (2024). Front. Nutr. 11:1371772. doi: 10.3389/fnut.2024.1371772
In the published article, there was an error in Table 2 as published. The starting and ending dose for the MAP and iMAP ladders were transposed. The starting dose of the MAP ladder is 95 mg and the starting dose of the iMAP ladder is 35 mg. The corrected Table 2 and its caption “Comparison of currently available milk ladders” appear below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: food allergy, cow's milk allergy, nutrition, food ladders, pediatric
Citation: Hicks A, Fleischer D and Venter C (2025) Corrigendum: The future of cow's milk allergy – milk ladders in IgE-mediated food allergy. Front. Nutr. 12:1521516. doi: 10.3389/fnut.2025.1521516
Received: 01 November 2024; Accepted: 17 March 2025;
Published: 01 April 2025.
Edited and reviewed by: Ronald van Ree, Amsterdam University Medical Center, Netherlands
Copyright © 2025 Hicks, Fleischer and Venter. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Carina Venter, Y2FyaW5hLnZlbnRlckBjaGlsZHJlbnNjb2xvcmFkby5vcmc=
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.